Characteristic | Results for: | P value | |
---|---|---|---|

Nonaspergillosis group (n = 83) | Aspergillosis group (n = 37) | ||

Sex (no. of males/no. of females) | 42/41 | 22/15 | 0.368^{a} |

Median (range) age (yr) | 52 (14–84) | 53 (14–85) | 0.949^{c} |

No. (%) of patients with the following underlying pulmonary diseases: | |||

COPD | 7 (8.43) | 5 (13.51) | 0.511^{b} |

Bronchiectasis | 15 (18.07) | 10 (27.03) | 0.265^{a} |

Previous tuberculosis | 9 (10.84) | 9 (24.32) | 0.056^{a} |

No. (%) of patients with the following extrapulmonary diseases: | |||

Diabetes mellitus | 6 (7.23) | 6 (16.22) | 0.185^{b} |

Hypertension | 12 (14.46) | 2 (5.41) | 0.222^{b} |

Chronic hepatitis | 5 (6.02) | 1 (2.70) | 0.665^{b} |

Cerebrovascular accident | 1 (1.20) | 1 (2.70) | 1^{b} |

Corticosteroid treatment | 6 (7.23) | 8 (21.62) | 0.032^{b} |

No underlying diseases | 33 (39.76) | 3 (8.11) | <0.001^{a} |

↵a χ

^{2}test.↵b Fisher's exact probability test.

↵c Mann-Whitney U test.

↵d Enumeration data were expressed as a percentage and analyzed by a χ

^{2}test, Fisher's exact probability test, or the Mann-Whitney U test. A*P*value of <0.05 was considered statistically significant. COPD, chronic obstructive pulmonary disease.